AVGR (Avinger Inc) חוב כולל להון

Avinger, Inc. (AVGR) is developing a network of specialized catheters, locking medical centers into its standards through staff training, although expansion rates are limited by FDA regulations. The uniqueness of the products lies in the ability to visualize plaques from within, which provides moderate pricing power. The price dynamics of the total debt-to-equity ratio are 1.39. Simultaneously, the business is minimizing production waste and improving workshop energy consumption in accordance with ESG principles.

This indicator compares total credit obligations against net assets, determining the business's reliance on debt financing and its resilience to rising interest rates. For Avinger, Inc. (AVGR), the company's debt-to-equity ratio demonstrates the financial capacity to execute M&A strategies and develop high-tech alliances in the field of vascular imaging without a critical risk of bankruptcy.